We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogeneric Approval Probe Bolsters Pathway Bill
Biogeneric Approval Probe Bolsters Pathway Bill
February 6, 2007
A congressional inquiry called to determine the adequacy of the FDA’s approval process for generic drugs might be a sign of strong support among lawmakers for legislation proposed last month that would create a clear pathway for follow-on biologics, according to industry sources.